EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Short Cognitive and Neuropsychiatric Assessment Scale for Progressive Supranuclear Palsy

Sonja Porsche iD, Martin Klietz iD, Stephan Greten iD, Ines A Piot, Ida Jensen iD, Florian Wegner, Lan Ye, Lea Krey, Matthias Höllerhage, Monika Pötter-Nerger iD, Molly Zeitzschel, Keno Hagena und 39 weitere

Movement Disorders Clinical Practice · 2025

DOI: 10.1002/mdc3.14348 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, 2025. Verfasst von Sonja Porsche und 50 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Hannover Medical School, Hannover, Germany. Hauptthemen laut MEDLINE: Supranuclear Palsy, Progressive, Neuropsychological Tests. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with Progressive Supranuclear Palsy (PSP) suffer from several neuropsychological impairments. These mainly affect the frontal lobe and subcortical brain structures. However, a scale for the assessment of cognitive and neuropsychiatric disability in PSP is still missing.

Objectives

To create and validate a new scale for cognitive and neuropsychiatric impairment in PSP.

Methods

The Short Cognitive and Neuropsychiatric (ShoCo) scale was developed containing five items (bradyphrenia, apathy, aphasia, dysexecution and disinhibition). Each item can be categorized into 0 = no deficit, 1 = mild deficit, 2 = moderate deficit and 3 = severe deficit. The total score includes 15 points, 0 meaning no deficit and 15 severe deficits. Cross‐sectional and longitudinal data from 201 baseline and 71 follow up patients were analyzed.

Results

Baseline ShoCo scale results were 5.9 ± 2.9. No significant differences between patients with Richardson syndrome (PSP‐RS) and variants (vPSP) could be detected in the PSP‐ShoCo scale scores (PSP‐RS 6.1 ± 3.0, n = 160, vPSP 5.1 ± 2.6, n = 41, P = 0.057). The scale showed good correlation with established scores (eg, Montreal cognitive assessment r = −0.535, P = 0.001). The ShoCo scale showed significant annualized change within the PSP‐RS patients (baseline 6.2 ± 2.9, follow up 6.9 ± 3.1, annualized diff. 1.0 ± 3.1, n = 57, P = 0.022).

Conclusions

The ShoCo scale seems a promising and valid tool to measure specific neuropsychological disabilities of PSP patients in clinical routine and research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Supranuclear Palsy, ProgressiveNeuropsychological TestsHumansMaleFemaleAgedCross-Sectional StudiesMiddle AgedAged, 80 and overLongitudinal StudiesSeverity of Illness Index

Stichwörter der Autor:innen

4‐repeat tauopathiesProgressive Supranuclear Palsycognitiondepressionquality of life

Autor:innen und Institutionen

  • Department of Neurology, Hannover Medical School, Hannover, Germany.
  • German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
  • Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.
  • Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Department of Neurology, University of Ulm, Ulm, Germany.
  • German Center for Neurodegenerative Diseases (DZNE), Ulm, Germany.

ORCID-Profile: Sonja Porsche, Martin Klietz, Stephan Greten, Ida Jensen, Monika Pötter-Nerger, Jan Kassubek, Lars Tönges, Florin Gandor, Wolfgang H Jost, Patricia Krause, Anja Schneider, Sabrina Katzdobler, Kathrin Brockmann, Gesine Respondek

Zitieren

APA

Porsche, S., Klietz, M., Greten, S., Piot, I. A., Jensen, I., Wegner, F., Ye, L., Krey, L., Höllerhage, M., Pötter-Nerger, M., Zeitzschel, M., Hagena, K., Kassubek, J., Süß, P., Winkler, J., Berg, D., Paschen, S., Tönges, L., Gruber, D., …, & Höglinger, G. U. (2025). A Short Cognitive and Neuropsychiatric Assessment Scale for Progressive Supranuclear Palsy. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.14348

Vancouver

Porsche S, Klietz M, Greten S, Piot IA, Jensen I, Wegner F, et al. A Short Cognitive and Neuropsychiatric Assessment Scale for Progressive Supranuclear Palsy. Movement Disorders Clinical Practice. 2025. doi:10.1002/mdc3.14348

BibTeX
@article{Porsche2025,
  author = {Porsche, Sonja and Klietz, Martin and Greten, Stephan and Piot, Ines A and Jensen, Ida and Wegner, Florian and Ye, Lan and Krey, Lea and Höllerhage, Matthias and Pötter-Nerger, Monika and Zeitzschel, Molly and Hagena, Keno and Kassubek, Jan and Süß, Patrick and Winkler, Jürgen and Berg, Daniela and Paschen, Steffen and Tönges, Lars and Gruber, Doreen and Gandor, Florin and Jost, Wolfgang H and Kühn, Andrea A and Claus, Inga and Warnecke, Tobias and Pedrosa, David J and Eggers, Carsten and Trenkwalder, Claudia and Classen, Joseph and Schwarz, Johannes and Schnitzler, Alfons and Krause, Patricia and Schneider, Anja and Brandt, Moritz and Falkenburger, Björn and Zerr, Inga and Bähr, Mathias and Weidinger, Endy and Levin, Johannes and Katzdobler, Sabrina and Düzel, Emrah and Glanz, Wenzel and Teipel, Stefan and Kilimann, Ingo and Prudlo, Johannes and Gasser, Thomas and Brockmann, Kathrin and Spottke, Annika and Esser, Anna and Petzold, Gabor C and Respondek, Gesine and Höglinger, Günter U},
  title = {A Short Cognitive and Neuropsychiatric Assessment Scale for Progressive Supranuclear Palsy},
  journal = {Movement Disorders Clinical Practice},
  year = {2025},
  doi = {10.1002/mdc3.14348}
}
Kostenlos starten →